SCHEMBL4155532

SCHEMBL4155532

CCNC(=O)c1cccc(C)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
MEN1 O00255 1/20 0.50
HPGD P15428 2/20 0.49
P2RX7 Q99572 6/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
TAS1R3 Q7RTX0 1/20 0.48
TAS1R1 Q7RTX1 1/20 0.48
TAS1R2 Q8TE23 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.46
MT-CO2 P00403 1/20 0.46
HTT P42858 4/20 0.45
TSHR P16473 2/20 0.45
LMNA P02545 1/20 0.45
TP53 P04637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
GAA P10253 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2228385 0.86 MEN1 (0.54) KMT2AMEN1HPGDP2RX7NPC1
SCHEMBL13477779 0.85 ALDH1A1 (0.58) KMT2AHPGDNPC1RAB9AL3MBTL1
SCHEMBL458942 0.85 HPGD (0.66) KMT2AMEN1HPGDP2RX7NPC1
SCHEMBL12677093 0.84 CA1 (0.50) KMT2AMEN1NPC1RAB9AL3MBTL1
SCHEMBL27919282 0.82 CD38 (0.48) KMT2AMEN1P2RX7NPC1RAB9A
SCHEMBL25078393 0.82 HTT (0.51) KMT2AHPGDP2RX7NPC1RAB9A
SCHEMBL15265662 0.82 HPGD (0.46) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL4517690 0.82 KMT2A (0.48) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL12164009 0.82 HPGD (0.46) KMT2AMEN1HPGDNPC1RAB9A
SCHEMBL15265668 0.82 L3MBTL1 (0.44) KMT2AHPGDL3MBTL1HTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090131657-A1 PROCESS FOR ALKENYLATING CARBOXAMIDES BASF SE (DE) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131657-A1 PROCESS FOR ALKENYLATING CARBOXAMIDES PRMT5, CYC1, CBR3 KMT2A 41/4885MEN1 303/4885HPGD 3495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.